Quantum BioPharma Ltd. (CSE:QNTM)

Canada flag Canada · Delayed Price · Currency is CAD
12.60
+0.60 (5.00%)
May 9, 2025, 9:30 AM EDT
-58.76%
Market Cap 32.48M
Revenue (ttm) n/a
Net Income (ttm) -20.44M
Shares Out 2.71M
EPS (ttm) -17.97
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 950
Average Volume 4,127
Open 12.37
Previous Close 12.00
Day's Range 12.37 - 12.60
52-Week Range 3.90 - 35.10
Beta 0.91
RSI 64.95
Earnings Date May 12, 2025

About Quantum BioPharma

Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company in the United States. It operates through two segments, Biopharmaceutical Innovation and Strategic Investments. The company researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to... [Read more]

Sector Healthcare
Founded 1998
Employees 17
Stock Exchange Canadian Securities Exchange
Ticker Symbol QNTM
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.